Dr. Ingmar Gorman on Psychedelic-Assisted Psychotherapy

41:47
 
공유
 

Manage episode 319126579 series 2911227
Player FM과 저희 커뮤니티의 Tatiana Irvine and Beth Weinstein 콘텐츠는 모두 원 저작자에게 속하며 Player FM이 아닌 작가가 저작권을 갖습니다. 오디오는 해당 서버에서 직접 스트리밍 됩니다. 구독 버튼을 눌러 Player FM에서 업데이트 현황을 확인하세요. 혹은 다른 팟캐스트 앱에서 URL을 불러오세요.

Dr. Ingmar Gorman is a Co-founder and Chief Executive Officer of Fluence, a psychedelic education company training mental health providers in psychedelic treatments. As a psychologist, he shares his expertise in empirically supported psychedelic treatments with his clients and trainees alike. Dr. Gorman received his clinical training in New York City at the New School for Social Research, Mount Sinai Beth Israel Hospital, Columbia University, and Bellevue Hospital. He completed his NIH postdoctoral fellowship at New York University. He simultaneously served as site co-principal investigator on an FDA approved Phase 3 clinical trial of MDMA-assisted Psychotherapy for Post-Traumatic Stress Disorder and is currently a study therapist on the same study, as well as another FDA approved clinical trial of psilocybin for treatment resistant depression. Dr. Gorman has published on the topics of classic psychedelics, ketamine, MDMA, and Psychedelic Harm Reduction and Integration.

In this episode, Beth and Dr. Gorman discuss …

  • Whether a psychedelic therapist needs to be licensed
  • The lack of protective mechanisms for clients that seek psychedelic therapy from unlicensed people
  • The power of being an integration support person
  • Psilocybin as an effective treatment for multiple psychiatric “disorders”
  • Spiritual bypassing in the psychedelic realm
  • How healing happens in relationship - not in a self-help vacuum

Free Gifts!

64 에피소드